4.6 Article

Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women

Journal

PLOS ONE
Volume 6, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0015949

Keywords

-

Funding

  1. NIH KO8 [1K08AI074907-01A1]
  2. Sanofi-Pasteur [CMEO1, U01-AI063565]
  3. NIH Center for Research Resources [5UL1 RR025777]

Ask authors/readers for more resources

Background: Infection with multiple CMV strains is common in immunocompromised hosts, but its occurrence in normal hosts has not been well-studied. Methods: We analyzed CMV strains longitudinally in women who acquired CMV while enrolled in a CMV glycoprotein B (gB) vaccine trial. Sequencing of four variable genes was performed in samples collected from seroconversion and up to 34 months thereafter. Results: 199 cultured isolates from 53 women and 65 original fluids from a subset of 19 women were sequenced. 51 women were infected with one strain each without evidence for genetic drift; only two women shed multiple strains. Genetic variability among strains increased with the number of sequenced genetic loci. Nevertheless, 13 of 53 women proved to be infected with an identical CMV strain based on sequencing at all four variable genes. CMV vaccine did not alter the degree of genetic diversity amongst strains. Conclusions: Primary CMV infection in healthy women nearly always involves shedding of one strain that remains stable over time. Immunization with CMVgB-1 vaccine strain is not selective against specific strains. Although 75% of women harbored their unique strain, or a strain shared with only one other woman, 25% shared a single common strain, suggesting that this predominant strain with a particular combination of genetic loci is advantageous in this large urban area.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo

Yi-Hsin Fan, Sujayita Roy, Rupkatha Mukhopadhyay, Arun Kapoor, Priya Duggal, Genevieve L. Wojcik, Robert F. Pass, Ravit Arav-Boger

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Immunology

Cytomegalovirus Kinetics Following Primary Infection in Healthy Women

Michael S. Forman, Dhananjay Vaidya, Oluwaseyi Bolorunduro, Marie Diener-West, Robert F. Pass, Ravit Arav-Boger

JOURNAL OF INFECTIOUS DISEASES (2017)

Article Multidisciplinary Sciences

HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions

Cody S. Nelson, Tori Huffman, Jennifer A. Jenks, Eduardo Cisneros de la Rosa, Guanhua Xie, Nathan Vandergrift, Robert F. Pass, Justin Pollara, Sallie R. Permar

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Editorial Material Immunology

Maternal Laboratory Assessment and Fetal Risk of Cytomegalovirus Infection

Robert F. Pass

CLINICAL INFECTIOUS DISEASES (2013)

Article Immunology

Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1-Infected Children, Adolescents, and Young Adults

Patricia M. Flynn, Sharon Nachman, Petronella Muresan, Terence Fenton, Stephen A. Spector, Coleen K. Cunningham, Robert Pass, Ram Yogev, Sandra Burchett, Barbara Heckman, Anthony Bloom, L. Jill Utech, Patricia Anthony, Elizabeth Petzold, Wende Levy, George K. Siberry, Ruth Ebiasah, Judi Miller, Edward Handelsman, Adriana Weinberg

JOURNAL OF INFECTIOUS DISEASES (2012)

Review Immunology

Priorities for CMV vaccine development

Philip R. Krause, Stephanie R. Bialek, Suresh B. Boppana, Paul D. Griffiths, Catherine A. Laughlin, Per Ljungman, Edward S. Mocarski, Robert F. Pass, Jennifer S. Read, Mark R. Schleiss, Stanley A. Plotkin

VACCINE (2013)

Review Immunology

Desirability and feasibility of a vaccine against cytomegalovirus

Paul Griffiths, Stanley Plotkin, Edward Mocarski, Robert Pass, Mark Schleiss, Philip Krause, Stephanie Bialek

VACCINE (2013)

Article Infectious Diseases

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth

Robert F. Pass, Sharon Nachman, Patricia M. Flynn, Petronella Muresan, Terence Fenton, Coleen K. Cunningham, William Borkowsky, James B. McAuley, Stephen A. Spector, Elizabeth Petzold, Wende Levy, George K. Siberry, Ed Handelsman, L. Jill Utech, Adriana Weinberg

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2013)

Article Infectious Diseases

Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection

Robert F. Pass, Brenna Anderson

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2014)

Editorial Material Immunology

Prenatal Cytomegalovirus Infection: Timing Is Everything

Robert F. Pass

CLINICAL INFECTIOUS DISEASES (2019)

Article Virology

Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees

Cody S. Nelson, Diana Vera Cruz, Melody Su, Guanhua Xie, Nathan Vandergrift, Robert F. Pass, Michael Forman, Marie Diener-West, Katia Koelle, Ravit Arav-Boger, Sallie R. Permar

JOURNAL OF VIROLOGY (2019)

Review Obstetrics & Gynecology

Cytomegalovirus infection during pregnancy: state of the science

Marianne Leruez-Ville, Ina Foulon, Robert Pass, Yves Ville

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)

Article Medicine, General & Internal

Drip System for Admissions to Resident Teams: Impact on Workload and Education

Stephanie Berger, Lauren B. Nassetta, Meghan E. Hofto, Paul Scalici, Robert F. Pass

SOUTHERN MEDICAL JOURNAL (2020)

Article Medicine, General & Internal

A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection

Brenna L. Hughes, Rebecca G. Clifton, Dwight J. Rouse, George R. Saade, Mara J. Dinsmoor, Uma M. Reddy, Robert Pass, Donna Allard, Gail Mallett, Lida M. Fette, Cynthia Gyamfi-Bannerman, Michael W. Varner, William H. Goodnight, Alan T. N. Tita, Maged M. Costantine, Geeta K. Swamy, Ronald S. Gibbs, Edward K. Chien, Suneet P. Chauhan, Yasser Y. El-Sayed, Brian M. Casey, Samuel Parry, Hyagriv N. Simhan, Peter G. Napolitano, George A. Macones

Summary: This study found that the use of CMV hyperimmune globulin during pregnancy did not reduce the incidence of congenital CMV infection or perinatal death compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cell Biology

Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans

Jennifer A. Jenks, Cody S. Nelson, Hunter K. Roark, Matthew L. Goodwin, Robert F. Pass, David Bernstein, Emmanuel B. Walter, Kathryn M. Edwards, Dai Wang, Tong-Ming Fu, Zhiqiang An, Cliburn Chan, Sallie R. Permar

SCIENCE TRANSLATIONAL MEDICINE (2020)

No Data Available